Two years ago, a consortium of scientists, lawyers, and entrepreneurs announced a plan to synthesize an artificial human genome from scratch—an extremely ambitious endeavor that’s struggled to secure funding. Project organizers have now disclosed details of a scaled-down version of the venture, but with a goal that’s…
For the first time, a research team from China used a new technique to fix a blood disorder in human embryos. The scientists performed “chemical surgery”—a procedure that rewrites errors in genetic code instead of snapping and replacing strands of faulty DNA, which is the central strategy employed by the CRISPR gene…
Listen, scientists. I appreciate what you do, and boy I sure do love that evidence-based pursuit of knowledge, but did you have to make mutant wasps? Did you?
A team of scientists in China has become the first to treat a human patient with the groundbreaking CRISPR-Cas9 gene-editing technique. While the results of the trial are uncertain, it’s a historic milestone that should serve as a serious wakeup call to the rest of the world.
Agriculture company Monsanto has acquired a non-exclusive global licensing agreement from MIT’s Broad Institute and Harvard to use the CRISPR/Cas9 gene-editing system. The firm will use it to design and grow new seeds and plants, but there are key restrictions on its use to prevent Monsanto from abusing this…
Last month, UFC mixed martial artist Jon Jones was busted for using an anti-estrogen drug known as hydroxy-clomiphene, as well as another drug, called Letrozole. Jones denied taking the drugs, claiming he didn’t even know how to pronounce them.
Most American adults are nervous about the prospect of enhancing humans beyond normal capacities, a new Pew Research Center poll reveals. But while many of those surveyed expressed concerns about brain-boosting chips and designer babies, a significant number had a positive view of technology’s ability to transform…
The burgeoning industry of biological design is in the headlines every day. Yet even science journalists have had trouble explaining concepts like CRISPR in terms that everyone can understand. A new exhibition at a Silicon Valley museum skillfully explains the technically and ethically complicated field of…
Leveraging the pre-existing power of CRISPR, a team of researchers has made an important adjustment to the groundbreaking gene-editing tool that could make it precise enough for human applications.
A mushroom that’s resistant to browning has become the first CRISPR-edited food to get green lit by the US government. Here’s how this mutated fungus managed to escape USDA oversight—and why this agency needs to upgrade its regulatory guidelines.
Just one year after scientists in China made history by modifying the DNA of human embryos, a second team of Chinese researchers has done it again. Using CRISPR/Cas9, the researchers introduced HIV-resistance into the embryos, showcasing the tremendous potential for gene-editing.
Scientists are excited about the prospect of using CRISPR, a powerful gene-editing tool, to combat HIV. A discouraging follow-up study shows that HIV is capable of developing a resistance to the genetic attack—but scientists say CRISPR’s battle with HIV is far from over.
Researchers from Temple University have used the CRISPR/Cas9 gene editing tool to clear out the entire HIV-1 genome from a patient’s infected immune cells. It’s a remarkable achievement that could have profound implications for the treatment of AIDS and other retroviruses.
Less than a year after scientists in China became the first to genetically modify human embryos, a research team in Britain has been given the green light to perform similar work. It’s a huge moment in biotech history—one that could eventually lead to “designer babies.”
Researchers in China are reportedly the first to use a powerful gene editing tool to produce super-muscled dogs. The goal is to create test subjects that mimic degenerative human diseases, but the breakthrough also raises the prospect of customized pets.
Editas Medicine hopes to use CRISPR—a revolutionary new gene-editing technology—to treat conditions such as sickle-cell anemia, cancer, and cystic fibrosis.
Scientists at Stanford University have found a way to program DNA in such a way that genes can be turned on or off in living cells. Incredibly, the new tool can affect two different genes at the same time, an advance that will allow scientists to treat even the most complex genetic disorders.
Sorry CRISPR, but there's a new genomic editor in town — and this one's better than you. It's a new approach to site-specific gene targeting that will allow scientists to safely replace disease-causing genes with functional copies. And they've already used it to relieve the effects of hemophilia in mice.
The treatment is considered radical, and the results were drawn from a small scale human trial, but for the first time in medical history, researchers have boosted their patients' ability to fight HIV by replacing some of their natural immune cells with genetically modified versions.